Skip to main content
TipRanks
Go Ultimate75% OFF
Engitix Ltd logo

Engitix Ltd: Valuation, Funding & Investors

21 Lombard Street London, England EC3V 9AH, GBhttps://www.engitix.com/Therapeutics

Engitix is a biotech company developing therapies that target the extracellular matrix (ECM) to treat cancer and fibrosis. The company integrates large-scale ECM datasets with translational biology and drug development to build a pipeline of therapeutics designed to act within diseased tissue microenvironments.

Leadership & Board

Current Number of Employees
65
Current LinkedIn Followers
10,101

Latest Estimated Valuation

Total Amount Raised
$25M
Total Funding Rounds
1
Latest Funding Amount
$25M
Latest Funding Round
Series A

Employee Trend

Engitix Ltd had 65 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.

65Latest Employee Count
0(0.00%)Week-Over-Week Change
020406080Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

Engitix Ltd had 10,101 followers as of November 9, 2026. The number of followers increased by 75 (0.75%) week-over-week.

10,101Latest Followers Count
75(0.75%)Week-Over-Week Change
05,00010,00015,00020,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jan 08, 2026Series A$25.00M―

Investors

Investor NameFunding Round
Netherton InvestmentsSeries A
Mike PlattSeries A

Similar Companies

A snapshot of private companies similar to Engitix Ltd, helping you discover and navigate related company profiles.

Related News and Analysis